Skip page top navigationFDA Logo--links to FDA home page Logo of and Link to start page of Office of Regulatory Affairs, U.S. Food and Drug Administration U.S. Food and Drug Administration Office of Regulatory Affairs HHS Logo and link to Department of Health and Human Services website

FDA Home Page | Federal-State | Import Program | Compliance | Inspection | Science | ORA Search

Program 7348.810
CHAPTER 48 - BIORESEARCH MONITORING
SPONSORS, CONTRACT RESEARCH ORGANIZATIONS AND MONITORS
Date of Issuance: February 21, 2001
Guidance for FDA Staff

 

This document is intended to provide guidance. It represents the Agency’s current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind Food and Drug Administration (FDA) or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statute and regulations.
Subject

SPONSORS, CONTRACT RESEARCH
ORGANIZATIONS AND MONITORS

Implementation Date

February 21, 2001
Completion Date

Continuing

Data Reporting

Product Codes

Product/Assignment Codes

45Z, 46Z
57Z, 99Z



60Z, 61Z
68Z, 69Z
73Z, 74Z
94Z, 95Z 

09810 Food Additives
41810 Therapeutics Products
42810 Blood and Blood Products
45810 Vaccines and Allergenic Products
48810 Human Drugs
68810 Veterinary Drugs
83810 Medical Devices and Radiological Health
Field Reporting Requirements

All establishment inspection reports (EIRs), complete with attachments, exhibits, and any post-inspectional correspondence are to be submitted promptly to the assigning Center. If an EIR contains serious findings that raise the possibility of one or more violations of the Federal Food Drug and Cosmetic Act (FFDCA) or other Federal statutes, a copy of the EIR should be forwarded to the District Compliance Branch at the time it is sent to the Center. When an FDA 483 is issued, a copy will be faxed to the Center contact identified in the assignment.

When the District becomes aware of any significant adverse inspectional, analytical, or other information which may affect the agency's new product approval decisions with respect to a firm, the District should immediately notify the responsible Center program office via electronic mail, fax, or by phone.

 

Hypertext updated April 5, 2001 tmc